Max Healthcare Institute Limited (NSE:MAXHEALTH)
India
· Delayed Price · Currency is INR 1,125.20
-10.00 (-0.88%)
May 30, 2025, 3:30 PM IST
Max Healthcare Institute Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Operating Revenue | 70,285 | 54,060 | 45,626 | 39,366 | 25,080 | Upgrade
|
| Revenue | 70,285 | 54,060 | 45,626 | 39,366 | 25,080 | Upgrade
|
| Revenue Growth (YoY) | 30.01% | 18.49% | 15.90% | 56.96% | 136.82% | Upgrade
|
| Cost of Revenue | 26,511 | 20,529 | 17,314 | 17,481 | 12,324 | Upgrade
|
| Gross Profit | 43,774 | 33,531 | 28,312 | 21,885 | 12,755 | Upgrade
|
| Selling, General & Admin | 14,747 | 11,169 | 9,863 | 8,729 | 5,657 | Upgrade
|
| Other Operating Expenses | 10,539 | 7,159 | 5,887 | 3,365 | 2,927 | Upgrade
|
| Operating Expenses | 28,880 | 20,778 | 18,072 | 14,305 | 10,325 | Upgrade
|
| Operating Income | 14,894 | 12,753 | 10,240 | 7,580 | 2,431 | Upgrade
|
| Interest Expense | -1,650 | -445.6 | -713.2 | -900.1 | -1,710 | Upgrade
|
| Interest & Investment Income | 1,172 | 1,562 | 1,124 | 750.9 | 767.3 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | -230.5 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 3 | -2.4 | -3.4 | 178.8 | Upgrade
|
| Other Non Operating Income (Expenses) | 384 | 41.6 | 86.7 | 207.3 | 67.4 | Upgrade
|
| EBT Excluding Unusual Items | 14,800 | 13,914 | 10,735 | 7,634 | 1,504 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | -90.3 | -377.8 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 4.5 | 13.3 | -30.6 | -2.4 | Upgrade
|
| Asset Writedown | - | - | - | -0.6 | -81.4 | Upgrade
|
| Other Unusual Items | -736.3 | -265.4 | -111.2 | -123.8 | -1,959 | Upgrade
|
| Pretax Income | 14,064 | 13,653 | 10,637 | 7,389 | -917 | Upgrade
|
| Income Tax Expense | 3,305 | 3,077 | -397.9 | 1,339 | 458.5 | Upgrade
|
| Earnings From Continuing Operations | 10,759 | 10,576 | 11,035 | 6,051 | -1,376 | Upgrade
|
| Net Income to Company | 10,759 | 10,576 | 11,035 | 6,051 | -1,376 | Upgrade
|
| Net Income | 10,759 | 10,576 | 11,035 | 6,051 | -1,376 | Upgrade
|
| Net Income to Common | 10,759 | 10,576 | 11,035 | 6,051 | -1,376 | Upgrade
|
| Net Income Growth | 1.73% | -4.16% | 82.38% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 972 | 972 | 970 | 967 | 863 | Upgrade
|
| Shares Outstanding (Diluted) | 977 | 975 | 972 | 969 | 863 | Upgrade
|
| Shares Change (YoY) | 0.18% | 0.39% | 0.24% | 12.30% | 47.77% | Upgrade
|
| EPS (Basic) | 11.07 | 10.89 | 11.38 | 6.25 | -1.59 | Upgrade
|
| EPS (Diluted) | 11.01 | 10.84 | 11.36 | 6.24 | -1.59 | Upgrade
|
| EPS Growth | 1.57% | -4.58% | 82.05% | - | - | Upgrade
|
| Free Cash Flow | 4,938 | 3,359 | 9,485 | 1,872 | -5.6 | Upgrade
|
| Free Cash Flow Per Share | 5.05 | 3.44 | 9.76 | 1.93 | -0.01 | Upgrade
|
| Dividend Per Share | 1.500 | 1.500 | 1.000 | - | - | Upgrade
|
| Dividend Growth | - | 50.00% | - | - | - | Upgrade
|
| Gross Margin | 62.28% | 62.02% | 62.05% | 55.59% | 50.86% | Upgrade
|
| Operating Margin | 21.19% | 23.59% | 22.44% | 19.25% | 9.69% | Upgrade
|
| Profit Margin | 15.31% | 19.56% | 24.19% | 15.37% | -5.49% | Upgrade
|
| Free Cash Flow Margin | 7.03% | 6.21% | 20.79% | 4.75% | -0.02% | Upgrade
|
| EBITDA | 18,005 | 14,819 | 12,226 | 9,465 | 3,896 | Upgrade
|
| EBITDA Margin | 25.62% | 27.41% | 26.80% | 24.04% | 15.53% | Upgrade
|
| D&A For EBITDA | 3,112 | 2,066 | 1,986 | 1,886 | 1,465 | Upgrade
|
| EBIT | 14,894 | 12,753 | 10,240 | 7,580 | 2,431 | Upgrade
|
| EBIT Margin | 21.19% | 23.59% | 22.44% | 19.25% | 9.69% | Upgrade
|
| Effective Tax Rate | 23.50% | 22.54% | - | 18.12% | - | Upgrade
|
| Revenue as Reported | 71,841 | 55,841 | 47,018 | 40,588 | 26,194 | Upgrade
|
| Advertising Expenses | - | - | - | 446.2 | 167.5 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.